PharmAsia News

PharmAsiaNews is an Elsevier Business Intelligence news daily focusing on the drug industry and its regulators in Asia. (Subscription required.)

Japan’s 2014 Drug Price Reforms Extend Price Premium Program (regulatory analysis)
Revised Rules for Japan’s Medical Devices Could Mean Speedier Time to Market (regulatory analysis)
Novartis Launches Japan Compliance Advisory Board in Wake of Diovan Turmoil (business)
PMDA’s Medical Information Project To Improve Adverse Effect Data In Japan (big data)
Japan’s PMDA Collecting Adverse Event Reports Directly From Patients  (technology)
Japanese Government to Tackle Preventative Health Care Using Big Data (regulatory analysis)